Cite
Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy
MLA
Yoshifumi Kadono, et al. “Quantification of Bone Metastasis of Castration-Resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.” Anticancer Research, vol. 39, no. 5, Mar. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e90f459c1aca590e50f934db4b43172&authtype=sso&custid=ns315887.
APA
Yoshifumi Kadono, Kazuyoshi Shigehara, Suguru Kadomoto, Shohei Kawaguchi, Takahiro Nohara, Masashi Iijima, Kenichi Nakajima, Atsushi Mizokami, Hiroshi Yaegashi, Kouji Izumi, & Kazufumi Nakashima. (2019). Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy. Anticancer Research, 39(5).
Chicago
Yoshifumi Kadono, Kazuyoshi Shigehara, Suguru Kadomoto, Shohei Kawaguchi, Takahiro Nohara, Masashi Iijima, Kenichi Nakajima, et al. 2019. “Quantification of Bone Metastasis of Castration-Resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.” Anticancer Research 39 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e90f459c1aca590e50f934db4b43172&authtype=sso&custid=ns315887.